Hematopoietic SCT has improved the survival rates of patients with hematologic and metabolic disorders, as well as those with malignancy or immunodeficiency. Although various complications have been reported following allogeneic SCT, phimosis has rarely been reported, and the predisposing risk factors for phimosis have not been determined. In this study, the occurrence of severe phimosis following allogeneic SCT in boys was analyzed, and its risk factors were determined. The patients were under 15 years of age. Phimosis was observed in 32.6% of 46 patients after allogeneic SCT; 13.0% of cases required surgery. On univariate analysis, risk factors for severe phimosis included chronic GVHD and the use of a conditioning regimen including anti-thymocyte globulin (ATG). Multivariate analysis showed that chronic GVHD was an independent risk factor for severe phimosis. Thus, severe phimosis is an important complication of SCT in boys, especially in patients with chronic GVHD.
Introduction
Although various complications have been reported following SCT, the number of long-term survivors is increasing. Given this background, late-onset complications following SCT are becoming important; such complications include endocrine, pulmonary, hepatic and gonadal disorders, as well as disorders of other organs. Urological problems after SCT have been reported previously, 1, 2 but are considered to be relatively rare. In female patients, genital tract problems after SCT have been associated with GVHD; 3 the occurrence of sexual problems after SCT has also been reported in recent years. We treated postallogeneic SCT patients with phimosis who developed subsequent urological disturbances that required surgical treatment. Our retrospective analysis showed that severe phimosis is an important complication of SCT. Reports of phimosis are rare, and we believe that out study is the first to describe the risk factors for phimosis after SCT in boys.
Patients and methods

Patients
Between February 1991 and November 2005, a total of 87 male patients under 15 years of age received allogeneic SCT in our hospital. None of the patients had previously been circumcised, as routine neonatal circumcision is not practiced in Japan. At the time of analysis, 28 male patients had died, 2 had moved to another hospital and 11 were unavailable for follow-up; thus, the remaining 46 patients were enrolled in the study. Of these patients, 16 had ALL, 6 had AML and 24 had other diseases, including four cases each of aplastic anemia and Wiskott-Aldrich syndrome; three cases each of myelodysplastic syndrome and Kostmann syndrome; two cases of X-linked SCID; and one case each of non-Hodgkin's lymphoma (NHL), CML, juvenile myelomonocytic leukemia, rhabdomyosarcoma, neuroblastoma, X-linked hyper-IgM syndrome, Hunter syndrome and Hurler-Scheie syndrome.
Thirty-two patients received BMT, and 14 received cord blood (CB) SCT. In 18 cases, the donors were HLA-matched siblings, in 1 case the donor was a one locusmismatched sibling, in 4 cases the donor was an HLAmatched or HLA-mismatched parent, in 16 cases the donor was an HLA-matched, unrelated donor, and in 7 cases the donor was a single locus HLA-mismatched unrelated donor. Conditioning regimens containing BU were used in 18 patients, TBI regimens were used in 26 patients, 7 patients received melphalan (L-PAM)-containing regimens, 34 received CY-containing regimens, 23 received etoposide (VP16)-containing regimens, and 10 received anti-thymocyte globulin (ATG)-containing regimens. Prophylaxis for GVHD included CsA and short-term (short) MTX in 20 patients, CsA and methylprednisolone (mPSL) in 12 patients, tacrolimus (FK506) and short MTX in 11 patients, and MTX alone in 3 patients. The median observation period was 1815 days (range: 296-5665 days); the data were analyzed as of 1 September 2006.
Evaluation and diagnosis of phimosis
Phimosis was defined as the presence of a non-retractable foreskin due to a narrow foreskin entrance; 4 adhesion of the prepuce to the glans was also included in the definition of phimosis. Severe phimosis was defined as phimosis requiring surgery owing to dysuria, a weak stream, preputial ballooning, pain on urination, a retrograde urinary tract infection, recurrent balanoposthitis or other urological problems caused by the phimosis. The point when these symptoms appeared was assumed to be the onset of severe phimosis. Every patient routinely had a genital examination. To assess the risk factors for severe phimosis after allogeneic SCT, a retrospective analysis of two groups was conducted: group A (n ¼ 6) consisted of patients with severe phimosis; and group B (n ¼ 40) consisted of patients who did not develop severe phimosis.
Evaluation and diagnosis of chronic GVHD Chronic GVHD was diagnosed when characteristic skin change (lichenoid or sclerodermatous lesions) or liver dysfunction or other organ damages occurred at late period after SCT, and, when other differential diagnosis were excluded. The skin biopsy was performed in one patient (case 3), and diagnosis of chronic GVHD was made. Tissue specimen of the foreskin was not obtained. Pulmonary or secretory gland function tests were not performed, because the patient had not developed pulmonary or secretary gland dysfunction; furthermore, they were too young to bear the various tests.
Statistical analysis
A t-or w 2 -test was used to compare patients with and without severe phimosis. To compare group A and group B, univariate analysis was used to determine the independence of following variables: age at SCT, stem cell source (BM or cord blood), donor (related or unrelated, HLA-matched or mismatched, and matched sibling or not (alternative)), disease (neoplastic or nonneoplastic), drugs-containing conditioning regimen (BU, CY, L-PAM, TBI, VP16 or ATG), GVHD prophylaxis (CsA þ short MTX, CsA þ mPSL, MTX alone or FK506 þ short MTX), acute GVHD (grade42 or 0-2) and chronic GVHD (occurrence or absence). Multivariate stepwise regression analysis was used to determine the independence of variables that were significant on univariate analysis. Statistical analyses were performed using Dr SPSS II for Windows (release 11.0.1J, SPSS Japan Inc). Po0.05 was considered to be statistically significant.
Results
Of the 46 patients, 15 (32.6%) developed phimosis and 6 (13.0%) developed severe phimosis. The profiles of patients with severe phimosis are shown in Table 1 . The median age at surgery for phimosis was 6.3 years (range: 2-11 years), the median time between SCT and the onset of severe phimosis was 388 days (range: 346-2532 days), and the median time between SCT and surgery was 880.5 days (range: 278-2725 days). Topical steroid therapy was applied in two cases (cases 4 and 6) before surgery, but Allogeneic SCT complicated by severe phimosis D Suzuki et al the therapy was ineffective. Of the six patients with severe phimosis, five (83.3%: except case 2) had chronic GVHD. One patient (case 3) had extensive chronic GVHD and developed sclerotic skin lesions on whole body. He underwent skin biopsy and the diagnosis of chronic GVHD was made. Other four patients had limited chronic GVHD. Of note, a Foley catheter or any other urinary tract medical instrument that could cause physical stimulation of the prepuce and glans was not used in any of the patients.
On univariate analysis, the risk factors for severe phimosis were a conditioning regimen including ATG and chronic GVHD ( Table 2 ). The drugs used in the conditioning regimens and for GVHD prophylaxis were not associated with severe phimosis. Multivariate analysis showed that chronic GVHD was an independent risk factor for severe phimosis (Table 3) .
Discussion
In this study, 15 of the 46 boys who received allogeneic SCT developed phimosis (32.6%), and 6 developed severe phimosis that required surgery (13.0%). None of the patients had urological symptoms before SCT, whereas six patients developed severe phimosis and obvious urological problems after SCT. Therefore, there appears to be a causal relationship between severe phimosis and SCT. Severe phimosis was more common in patients with chronic GVHD; none of the other parameters were significantly related to the development of severe phimosis. In another aspect, severe phimosis itself might be a part of the lesion of cutaneous chronic GVHD.
It was initially assumed that TBI may have affected the incidence of phimosis through the development of radiation dermatitis, 5 but no significant relationship was found between TBI and the development of phimosis.
There are two main types of cutaneous chronic GVHD, lichenoid or sclerodermatous lesions. 6 Lichenoid lesions usually affect the periorbital region, the ears, palms and soles. These lesions sometimes affect the external genitalia; female patients may present with vaginal stenosis. 7 On the other hand, sclerodermatous lesions appear later than the lichenoid lesions. Sclerodermatous lesions may develop particularly on the legs, and the skin can become so adherent to deeper tissues that mechanical ulcers can develop. Kami et al. 8 reported a patient who developed sclerodermatous changes on the foreskin after allogeneic SCT, which ultimately resulted in a contracted foreskin. One of our cases (case 3) also developed sclerotic lesions and a severe phimosis with a contracted foreskin. However, the other five severe phimosis patients did not develop such sclerotic lesions.
During fetal life, the prepuce and glans adhere; the prepuce can be retracted completely in only 4% of newborn boys. 9 Separation of the prepuce and glans usually proceeds with growth, so phimosis in infancy and early childhood is sometimes called physical phimosis. However, partial preputial adhesion remains in 63% of 6-to 7-year-olds. 8 The existence of partial preputial adhesion might be contributory to the occurrence of severe phimosis. Although there are various opinions about the medical treatment of phimosis, topical steroid therapy is becoming the standard initial treatment for phimosis. 10, 11 In our study, topical steroid applied in two cases before surgery was ineffective. Nevertheless, topical application of steroid may prevent the deterioration of phimosis and it may be considered as a treatment for patients presenting with phimosis after SCT.
Our data show that severe phimosis is an important complication of SCT, especially in patients with chronic GVHD. Since phimosis not only causes urological disturbances but may also decrease quality of life and have adverse psychological effects, it is important to recognize that this condition can occur as a complication of SCT. 
